These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27226132)

  • 1. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.
    Robinson BM; Akizawa T; Jager KJ; Kerr PG; Saran R; Pisoni RL
    Lancet; 2016 Jul; 388(10041):294-306. PubMed ID: 27226132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Thurlow JS; Joshi M; Yan G; Norris KC; Agodoa LY; Yuan CM; Nee R
    Am J Nephrol; 2021; 52(2):98-107. PubMed ID: 33752206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group.
    Shroff R; Calder F; Bakkaloğlu S; Nagler EV; Stuart S; Stronach L; Schmitt CP; Heckert KH; Bourquelot P; Wagner AM; Paglialonga F; Mitra S; Stefanidis CJ;
    Nephrol Dial Transplant; 2019 Oct; 34(10):1746-1765. PubMed ID: 30859187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the European EDITH nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease.
    de Jong RW; Jager KJ; Vanholder RC; Couchoud C; Murphy M; Rahmel A; Massy ZA; Stel VS
    Nephrol Dial Transplant; 2021 Dec; 37(1):126-138. PubMed ID: 33486525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study on the lived experiences of individuals with end-stage kidney disease (ESKD) accessing haemodialysis in Northern Ghana.
    Boateng EA; Iddrisu AA; Kyei-Dompim J; Amooba PA
    BMC Nephrol; 2024 May; 25(1):186. PubMed ID: 38822254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal replacement therapy in Brunei Darussalam: comparing standards with international renal registries.
    Tan J
    Nephrology (Carlton); 2014 May; 19(5):288-95. PubMed ID: 24641721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advance care planning for haemodialysis patients.
    Lim CE; Ng RW; Cheng NC; Cigolini M; Kwok C; Brennan F
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010737. PubMed ID: 27457661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and incidence of chronic kidney disease stage G5 in Japan.
    Yamagata K; Yagisawa T; Nakai S; Nakayama M; Imai E; Hattori M; Iseki K; Akiba T
    Clin Exp Nephrol; 2015 Feb; 19(1):54-64. PubMed ID: 24821288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of supplemental private health insurance on dialysis and outcomes.
    Sriravindrarajah A; Kotwal SS; Sen S; McDonald S; Jardine M; Cass A; Gallagher M
    Intern Med J; 2020 May; 50(5):542-549. PubMed ID: 31111611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
    Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
    Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014.
    Kainz A; Berner C; Ristl R; Simon A; Stamm T; Zitt E; Kramar R; Antlanger M; Kautzky-Willer A; Schmaldienst S; Schernhammer E; Port FK; Carrero JJ; Jager KJ; Hecking M
    Nephrol Dial Transplant; 2019 Jun; 34(6):1026-1035. PubMed ID: 30476247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
    Webster AC; Irish AB; Kelly PJ
    Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.
    van de Luijtgaarden MW; Jager KJ; Segelmark M; Pascual J; Collart F; Hemke AC; Remón C; Metcalfe W; Miguel A; Kramar R; Aasarød K; Abu Hanna A; Krediet RT; Schön S; Ravani P; Caskey FJ; Couchoud C; Palsson R; Wanner C; Finne P; Noordzij M
    Nephrol Dial Transplant; 2016 Jan; 31(1):120-8. PubMed ID: 26311215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine approach to dialysis including incremental and decremental dialysis regimens.
    Murea M
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):85-92. PubMed ID: 33165001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design.
    van Eck van der Sluijs A; Bonenkamp AA; Dekker FW; Abrahams AC; van Jaarsveld BC;
    BMC Nephrol; 2019 Sep; 20(1):361. PubMed ID: 31533665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported factors influencing the choice of their kidney replacement treatment modality.
    de Jong RW; Stel VS; Rahmel A; Murphy M; Vanholder RC; Massy ZA; Jager KJ
    Nephrol Dial Transplant; 2022 Feb; 37(3):477-488. PubMed ID: 33677544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present and future of kidney replacement therapy in Italy: the perspective from Italian Dialysis and Transplantation Registry (IDTR).
    Nordio M; Limido A; Postorino M;
    J Nephrol; 2020 Dec; 33(6):1195-1200. PubMed ID: 32445008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study.
    Palmer SC; Ruospo M; Campbell KL; Garcia Larsen V; Saglimbene V; Natale P; Gargano L; Craig JC; Johnson DW; Tonelli M; Knight J; Bednarek-Skublewska A; Celia E; Del Castillo D; Dulawa J; Ecder T; Fabricius E; Frazão JM; Gelfman R; Hoischen SH; Schön S; Stroumza P; Timofte D; Török M; Hegbrant J; Wollheim C; Frantzen L; Strippoli GF;
    BMJ Open; 2015 Mar; 5(3):e006897. PubMed ID: 25795691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.